A
Aytu BioPharma
AYTU
2.60000
USD
-0.05
(-1.89%)
مغلق
حجم التداول
113
الربح لكل سهم
0
العائد الربحي
0
P/E
-1
حجم السوق
13,198,843
الأخبار
العنوان: Aytu BioPharma
القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complimentary therapeutic development pipeline including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidityand a significantly shortened lifespan. AR101/enzastaurin has received Orphan Drug designation from the FDA. The company operates in two segments Rx Segment, consisting of prescription pharmaceutical products and Consumer Health segments of which it generates maximum revenue from the Rx segment.